Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States
May 1, 2016, 00:00
10.1016/j.jval.2016.03.029
https://www.valueinhealthjournal.com/article/S1098-3015(16)00097-8/fulltext
Title :
Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00097-8&doi=10.1016/j.jval.2016.03.029
First page :
A3
Section Title :
Cardiovascular Outcomes Studies
Open access? :
No
Section Order :
1233